The treatment for COVID-19 has evolved rapidly since the start of the pandemic and now
consists mainly of antiviral and immunomodulatory agents. Antivirals, such as remdesivir …

Background Single studies support the presence of several post‐COVID‐19 symptoms;
however, there is no evidence for the synthesis of symptoms. Objective We attempt to …

Abstract Aims and Objectives To determine the frequency, timing, and duration of post‐acute
sequelae of SARS‐CoV‐2 infection (PASC) and their impact on health and function …

Objective To determine whether initiating saline nasal irrigation after COVID-19 diagnosis
reduces hospitalization and death in high-risk outpatients compared with observational …

More than four years have passed since an inimitable coronavirus disease (COVID-19)
pandemic hit the globe in 2019 after an uncontrolled transmission of the severe acute …

Abstract Although SARS-CoV-2, responsible for COVID-19, is primarily a respiratory
infection, a broad spectrum of cardiac, pulmonary, neurologic, and metabolic complications …

Post-COVID-19 conditions (PCC) is an umbrella term that encompasses a range of signs,
symptoms and conditions present weeks after the acute phase of a SARS-CoV-2 infection …

The COVID-19 pandemic continues to cause severe global disruption, resulting in significant
excess mortality, overwhelming healthcare systems, and imposing substantial social and …

Throughout the COVID-19 pandemic, the new clinical entity of the post-COVID-19 condition,
defined as a multisystemic condition of persistent symptoms following resolution of an acute …

Background Prior research has revealed notable declines in health-related quality of life
(HRQoL) and substantial psychological impacts among individuals infected with COVID-19 …